Guinea pig antisera were prepared against purified hexon, penton and fibre antigens of adenovirus type 5. Sera reacting specifically with particular antigens as judged by immunodiffusion, complement fixation and haemagglutination-inhibition tests were assayed for virus neutralizing capacity. The latter was exerted almost exclusively by anti-hexon sera. Type 5 anti-hexon but not anti-fibre sera neutralized type I virus provided the serum virus reaction took place at low pH values.
INTRODUCTION
The nature of the adenovirus antigenic component or components responsible for the stimulation of neutralizing antibodies is of considerable theoretical and practical interest. That adenovirus soluble antigens can stimulate virus neutralizing antibody production in human subjects was demonstrated by Kasel et aL 0964). Wilcox & Ginsberg (i963) presented evidence that both the hexon and the fibre antigens of adenovirus type 5 gave rise to neutralizing antibodies in rabbits. The latter finding was rather unexpected as the hexon behaves as a group-specific antigen in the usual serological tests while the fibre antigen is type-specific. In order to explain their finding Wilcox & Ginsberg suggested that the hexon antigen might be formed of several components, only part of which would be group specific. Evidence in favour * Present Address: Institute for Medical Microbiology, Department of Virology, S/31vegatan 23, Lurid, Sweden.
x a J. Virol. z of this hypothesis was presented by K~Shler (I965) on the basis of immunodiffusion tests which indicated a complex structure of the hexon antigen of adenovirus type 2. However, no type specific components from the hexon antigen have so far been isolated and described.
In the present report evidence will be presented indicating that the hexon is the main antigen involved in the neutralization of adenoviruses by antibody. Evidence will also be presented to show that subgroup heterotypic rabbit antibody combines with adenovirus type 5 without neutralizing its infectivity except when the reaction takes place at low pH values or in the presence of homotypic serum.
METHODS
Virus strains. The prototype strains of adenovirus I, 2, 3, 5, i2 and 2I and the 5r variant of adenovirus 5 were used as indicated.
Preparation of purified antigens. HeLa cells infected with the prototype strain of adenovirus 5 were treated with fluorocarbon (Gessler, Bender & Parkinson, I956) and the resulting material fractionated by chromotography on DEAE-cellulose as described by Klemperer & Pereira (I959) . Purified antigens were obtained after three or four successive fractionations.
Digestion with proteolytic enzymes. Purified antigens were digested with oq % pronase (Calbiochem) or o-1% crystalline trypsin (Armour) for 30 min. at 37 °.
Guinea-pig antisera. Unfractionated or purified adenovirus 5 antigens were emulsified in complete Freund's adjuvant and inoculated in o.t ml. volumes into each of the foot pads of a guinea pig. An intramuscular inoculation of 0"5 ml. of the same preparation was given 2 weeks later and the animals were bled after a further week.
Rabbit antisera. Hyperimmune rabbit antisera against adenovirus types 5 r, prototypes I, 2, 3, I2 and 2I, were prepared according to the immunization schedule described previously (Kjellrn, I965).
Rabbit lgG. IgG of adenovirus type 5 was prepared by two precipitations with Na~SO4 according to Kekwick (I94o) and subsequent chromatography on DEAEcellulose using o.oi M-phosphate buffer at pH 8"0. IgG derived from antisera to adenovirus types t, 2, 3, I2 and coxsackie B6 were prepared by filtration of 3 ml. of serum through Sephadex G 200 (2"5 x 45 cm.) using phosphate buffered saline (PBS) at pH 7"4 (Flodin & Killander, I962).
Immunodiffusion (ID) tests were performed as described by Pereira, Pereira &
Allison (I959).
Complement fixation (CF) tests were performed in WHO Perspex plates. Each reagent was added in a volume of 0"025 ml. Serial twofold serum dilutions, starting at I/5 or 1[Io, were tested against twofold antigen dilutions ranging from I/io to I/I28o. Fixation was allowed to take place overnight at 4 ° and end points were given as the serum dilution giving 50 % fixation of two units of complement in the presence of the optimum antigen dilution.
Haemagglutination-inhibition (HA1) tests were performed as described by Rosen I96o).
Virus assay methods. In the neutralization tests the prototype strain of adenovirus I or the rapid plaque-forming variant 5r of adenovirus type5 (Kjellrn, I963)were used throughout. The virus material used consisted of extracts of infected cells obtained by the technique of Gessler et al. (I 956) using the fluorocarbon compound Arcton (I.C.I. Ltd). 113. In some exoeriments (see text) the virus inoculum consisted of preparations further purified by density-gradient centrifugation in CsCI. Batches were diluted in lactalbumin hydrolysate and stored at -20 °. The preparation of monolayers of MAS cells, the tissue culture media and the plaque assay method have been described previously (Kjell6n, 196I) .
Virus neutralization (VN) tests. The neutralizing capacity of the guinea-pig sera immunized with different type 5 antigens were tested at dilutions indicated in the text against a fixed amount of adenovirus type 5. The tests were standardized to contain about IOO p.f.u./monolayer. Each dilution was tested in 3 to 5 monolayers. Titres were taken as the highest serum dilution reducing the number of plaques by more than 30 %. In some experiments samples of serum + virus mixtures were incubated at pH 2"5 and 7"4 respectively before dilution and plating, as described by Kjell6n (1966) . In such experiments, virus controls incubated at pH 2"5 were included.
Heterotypic combination between type 5 virus and type I, 2, 3, I2, 2i and Coxsackie B 6 rabbit antisera was tested by adding anti-rabbit-H-chain serum (kindly supplied by Dr F. Karush, Philadelphia, U.S.A.) to mixtures of virus and rabbit antisera listed above (see Table 2 ).
Enhancement of homologous neutralization by heterotypic sera was tested by adding IgG fractions of type I, 2, 3 and I2 antisera to adenovirus 5 partially neutralized (25% survival) by homologous IgG (see Table 3 ).
RESULTS

Immune response to adenovirus type 5 antigens
Sera from guinea pigs immunized with either unfractionated or purified antigens were tested by immunodiffusion, complement fixation, haemagglutination-inhibition and virus neutralization ( Table I ). The specific antibody responses revealed by immunodiffusion and by complement fixation indicated a high degree of purity of the antigens used. Cross-reactions were only observed, as expected, between the penton and fibre antigens, which have been shown to share certain antigenic components (Pereira, 196o ) . Additional evidence indicating purity of the hexon antigen is provided by the failure of preparations containing hexon antigen alone to induce the production of HAI antibodies. It should be noted that sera from a number of guinea pigs immunized with other antigen preparations obtained by the same method behaved in essentially the same manner. All animals immunized with unfractionated antigens or with hexon antigen responded with formation of virus neutralizing antibody. Only one of the two anti-penton sera showed a low VN titre whereas none of the anti-fibre sera exhibited VN activities. Negative results were also obtained when anti-fibre sera were tested against virus purified by density gradient centrifugation.
It is generally accepted that the hexon antigen holds the group specific complement fixing determinant shared by all members of the adenovirus group. A series of experiments was performed attempting to discover whether type specific determinants could be found as additional components of the hexon. Purified hexon antigens digested with trypsin or pronase were fractionated on the DEAE-cellulose columns. After trypsin digestion, the hexon antigen, which normally elutes from these columns at o'25 to o'3 i-NaCl, had an altered elution pattern with two separate peaks at o'375 I2-2 and 0"25 M-NaCI respectively. Materials from these two peaks showed consistent elution patterns on recycling. No antigenic difference could, however, be found between the fractions and both of them still elicited neutralizing antibody when inoculated into guinea pigs.
Pronase digestion had also a marked influence on the elution pattern of the antigen, displacing the elution peak from 0-25-0. 3 M to O-I M-NaCI. Immune sera produced in response to this antigen still possessed neutralizing capacity, and although the titres were reduced, the ratios of VN to CF titres were not significantly different from those obtained with antisera to untreated hexon or to unfractionated antigen (Table ~) 
Capacity of type 5 anti-hexon antibody to neutralize type I virus
In a previous report (Kjell6n, 1966) evidence was presented indicating that adeno type I immune serum neutralized type 5 virus provided that the virus+antibody mixtures were preincubated at pH 2"5; no neutralization occurred at approximate It was tentatively inferred that at low pH values conformational changes might occur in the capsid pattern of the virus. Common determinants otherwise obscured would thus be reached by the common hexon antibody. In the present report antisera specific for adeno 5 hexon or fibre were tested for capacity to neutralize adenovirus type I. Fig. I illustrates the development of plaques induced by those mixtures that were preincubated at low pH. Plaques from mixtures of type I virus + type 5 antihexon antiserum developed later and the final number of plaques on the I5th day was significantly lower than the number produced by control virus as well as by the mixture of virus + antifibre antiserum. No plaque reduction was found in the mixtures treated at pH 7"4 ( Fig. x) . Type 5 anti-hexon antibody is thus able to neutralize type I virus but the antigenic determinants involved in this reaction are not reached unless virus and antibody are allowed to react at low pH values.
Capacity of heterotypic adenovirus antisera to combine with type 5 virus
This was investigated by means of a technique based on the findings of Goodman & Donch 0965), who showed that specific goat anti-rabbit globulin enhanced the relatively weak neutralization of phage by polypeptide chains of rabbit antibody. I to IO x Io s p.f.u, of adenovirus 5 were suspended in 3 ml. of serum dilutions (column I) and incubated at room temperature for 2 hr. One sample of each mixture was diluted and assayed for plaque formation and another added to an equal volume of a I/IOo dilution of goat anti-rabbit-Hchain serum, incubated for 2 hr at room temperature and assayed for plaque formation. Notkins et al. (I966) recently used a similar technique in order to determine virus sensitization, i.e. attachment of specific antibody, without neutralization, to lactic dehydrogenase and herpes viruses (Ashe & Notkins, I966) . Accordingly, adenovirus type 5 was first exposed to heterotypic rabbit immune sera previously shown to have good homologous neutralizing activity but to lack the capacity to neutralize adeno 5, and then to goat anti-rabbit-H-chain serum. A subsequent 'artificial' neutralization, estimated by a reduced surviving fraction of virus, was considered as evidence of combination between adeno 5 and heterotypic sera.
The addition of goat anti-rabbit serum caused a marked enhancement of the typespecific homologous reaction between type 5 virus and a diluted amount of type 5 IgG. (Table z) . This result confirms a previous finding (Kjell6n, I965) that homologous antibody may combine with virus without necessarily causing inactivation. It may furthermore be seen from Table 2 that type I and type 2 antisera became attached to Approximately Ios of adenovirus type 5 were suspended in 2 ml. of PBS or homologous IgG diluted I/iooo and incubated at room temperature for 2 hr. Half ml. of each mixture was added to 0"5 ml. of heterotypic IgG diluted I/Io, reincubated for 2 hr at room temperature and assayed for plaque production.
Insignificant differences from the control were designated as I.O. The dilution factor was compensated for. t~ type 5 virus particles but did not neutralize infectivity. This is indicated by the fact that a subsequent addition of anti-rabbit serum resulted in a significant reduction of surviving virus. No combinations between type 5 virus and sera of type 3, 12 or 2I could be demonstrated by the present 'sandwich' technique. Adenovirus I and 2 antibodies may thus become attached to the surface of the closely related adenovirus 5 virus particles, but under ordinary conditions lack the ability to reach the 'critical" sites involved in virus inactivation.
From the results described above it may be concluded that the hexon antigen of type 5 virus is responsible for the stimulation of neutralizing antibody; and that hexon antibody is capable of neutralizing the closely related type I virus (and vice versa) provided that the mixture is preincubated at low pH values. At pH values near to neutrality, type I and type 2 antibody combine with but do not neutralize type 5 virus particles. Itthus seems likelythatcross-reacting antibody present in heterotypic adenovirus antisera can neutralize type 5 virus provided that common critical sites are reached. This might be achieved by exposing type-specific reactive sites presumed to exist in the hexon either by changes in electrostatic forces (low pH) or by concurrent binding of antibody to other sites in the virion. This latter possibility was examined experimentally. Although type I, type 2 and type 12 IgG had by themselves no virus inactivating capacity they caused significant enhancement of inactivation of the homologous type 5 virus antibody complexes. Type 3 IgG as well as Coxsackie B 6 IgG had no such enhancing capacity demonstrable by the present technique (Table 3) .
DISCUSSION
These results confirm the finding of Wilcox & Ginsberg (1963) that the immune response leading to production of adenovirus type 5 neutralizing antibody is mainly elicited by the hexon antigen. However, in contrast to Wilcox & Ginsberg we failed to demonstrate any virus inactivating capacity of the antibody formed in response to the type-specific fibre antigen. The seemingly paradoxical situation of an immune response to the group antigen resulting in a type-specific reaction has not been completely explained, as we have not been able to identify the postulated type-specific component or components of the hexon antigen. Our attempts to demonstrate such components by digestion of purified hexon with proteolytic enzymes was based on a previous observation (unpublished) that sera from rabbits immunized with adenovirus soluble antigens digested with trypsin may lack virus neutralizing activity. Although this finding could not be reproduced in the present study, further work along these lines would seem worth while.
The present results offer a hint as to the possible mechanism responsible for the neutralization of adenoviruses. The presence of type-specific components in the hexon is suggested by the finding that homologous IgG combined with the adenovirus type 5 particles dears the way in a manner that permits subsequently added heterotypic antibody to reach common critical sites involved in the inactivation procedure. Such ability was found in the heterotypic sera to adenovirus type I and 2 and 12 but not to type 3, suggesting the involvement of subgroup-specific components in this reaction. It seems justified therefore to assume that critical sites involved in inactivation of virus are located inside the capsid, presumably involving structures between the capsomeres and the underlying core. Type-specific antibody may combine initially with super-ficial structures causing conformational changes which may permit common antibody to reach critical sites. A similar conformational change in the adenovirus capsid may also be achieved by treatment at low pH. The interpretation that treatment at low pH values may open the capsid structure in a way that makes it possible for heterotypic antibody to reach critical sites has some support in the recent report by Bancroft, Hills & Markham 0967) who demonstrated that the cowpea chlorotic mottle virus capsid swells when the pH value is raised from pH 5 to pH 7"3 and so exposes its nucleic acid to attack by nucleases. The swelling is reversible.
It should also be mentioned in this connexion that Morgan (personal communication) has evidence that ferritin-labelled anti-type 5 antibody in electron micrographs may be found 'inside' rather than on the surface of the virus particle.
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